KOMISJA NADZORU FINANSOWEGO | ||||||||||||
Raport bieżący nr | 11 | / | 2021 | |||||||||
Data sporządzenia: | 2021-04-13 | |||||||||||
Skrócona nazwa emitenta | ||||||||||||
MILESTONE MEDICAL | ||||||||||||
Temat | ||||||||||||
The Retirement of Chief Financial Officer | ||||||||||||
Podstawa prawna | ||||||||||||
Art. 17 ust. 1 MAR - informacje poufne. | ||||||||||||
Treść raportu: | ||||||||||||
The Board of Directors of Milestone Medical Inc. (WAR: MMD, “the Company", “the Issuer") today announced the retirement of Joseph D’Agostino, the Company’s Chief Financial Officer. Mr. D’Agostino, age 70, has been instrumental in overseeing treasury and cash management, strategic planning, information technology, internal controls, operations, and financial and tax accounting. Mr. D'Agostino has been Chief Financial Officer since the Company's founding in March 2011. The Board of Directors of the Company has hired an executive search firm to assist in the identification and selection of a new Chief Financial Officer. The Board of Directors of the Company believes its current financial and accounting team will be sufficient to support ongoing operations and financial reporting. Mr. D’Agostino will continue as an advisor to the Company. |
MESSAGE (ENGLISH VERSION) |
MILESTONE MEDICAL INC | ||||||||||||||||
(pełna nazwa emitenta) | ||||||||||||||||
MILESTONE MEDICAL | ||||||||||||||||
(skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | |||||||||||||||
NJ 07039 | . | |||||||||||||||
(kod pocztowy) | (miejscowość) | |||||||||||||||
South Orange Avenue Livingston | 220 | |||||||||||||||
(ulica) | (numer) | |||||||||||||||
+11 973 535 2717 | +11 973 535 2829 | |||||||||||||||
(telefon) | (fax) | |||||||||||||||
(e-mail) | (www) | |||||||||||||||
27-5484393 | ||||||||||||||||
(NIP) | (REGON) |
PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
2021-04-13 | Leonard Osser | Interim Chief Executive Officer | Leonard Osser |